Results 141 to 150 of about 38,962 (211)

Real World Experience with use of Coagulation Factor VIIa at an Academic Medical Center. [PDF]

Clin Appl Thromb Hemost
George AR, Sylvester KW, Kanaan DM, Reddy P, Fanikos JR, Connors JM, Connell NT.   +6 more
europepmc   +1 more source

Future options for UK fish quota management [PDF]

, 2002
Arnason, Ragnar, Banks, Richard, Hatcher, Aaron, Pascoe, Sean   +3 more
core  

Conformational Plasticity-Rigidity Axis of the Coagulation Factor VII Zymogen Elucidated by Atomistic Simulations of the N-Terminally Truncated Factor VIIa Protease Domain. [PDF]

Biomolecules, 2021
Madsen JJ, Olsen OH.
europepmc   +1 more source

Recombinant Activated Factor VIIa Combined With Tranexamic Acid Control Haemostasis in Patients With Severe Factor XI Deficiency Undergoing Urological Procedures. [PDF]

Haemophilia
Sternbach N, Ehrlich Y, Stenevsky A, Saidian D, Elhalim DA, Baniel J, Raanani P, Spectre G.   +7 more
europepmc   +1 more source

Good metabolic control is associated with decreased circulating factor VIIa- antithrombin complexes in type 2 diabetes: a cross-sectional study. [PDF]

Cardiovasc Diabetol
Gastoł J, Paszek E, Bryk-Wiązania A, Matejko B, Undas A.   +4 more
europepmc   +1 more source

Efficacy and Safety Analyses of Recombinant Factor VIIa in Severe Post-Partum Hemorrhage. [PDF]

J Clin Med
Caram-Deelder C, McKinnon Edwards H, Zdanowicz JA, van den Akker T, Birkegård C, Blatný J, van der Bom JG, Colucci G, van Duuren D, van Geloven N, Henriquez DDCA, Knight M, Korsholm L, Landorph A, Lavigne Lissalde G, McQuilten ZK, Surbek D, Wellard C, Wood EM, Mercier FJ.   +19 more
europepmc   +1 more source

Factor VIIa induces extracellular vesicles from the endothelium: a potential mechanism for its hemostatic effect.

Blood, 2021
Das K, Keshava S, Ansari SA, Kondreddy V, Esmon CT, Griffin JH, Pendurthi UR, Rao LVM.   +7 more
europepmc   +1 more source

Factor VIIa product

Japanese Journal of Thrombosis and Hemostasis, 2009
Mitsuhiro KUWAHARA, Morio ARAI
openaire   +2 more sources

The anticoagulant effects of milvexian, a novel small molecule factor XIa inhibitor, are neutralized by activated prothrombin complex concentrates and recombinant factor VIIa in human plasma and whole blood in vitro. [PDF]

Res Pract Thromb Haemost
Bunce M, Huang Devine Z, Chintala M.
europepmc   +1 more source

CT-001, a novel fast-clearing factor VIIa, enhanced the hemostatic activity in postpartum samples. [PDF]

Blood Adv
Sim DS, Mallari CR, Hermiston TW, Bae D, Lee S, Allen T, Gilner J, Kim SC, James AH.   +8 more
europepmc   +1 more source